Technical Workshop and Exhibition : DTM2025

2025.10.22

Provigate, Inc. will be exhibiting at the 25th Annual Diabetes Technology Meeting (DTM), an international conference held in Burlingame, California, USA, from October 28 to 30, 2025.
In addition, our CEO, Koshin Sekimizu, will give a presentation at a Technical Workshop on October 28 at 3:50 PM. DTM is one of the leading international conferences in the field of diabetes technology. At this meeting, we will present the latest research findings and development trends related to our low/non-invasive blood glucose management technology.

Registration is required to attend the conference. For details on registration and fees, please refer to the official website:
https://www.diabetestechnology.org/dtm/registration.shtml
We look forward to welcoming you to our booth and workshop!

Panel Theme
New Technology to Measure Glucose: Glycated Albumin (GA)

Date & Time
October 28, 2025 (Tuesday) – 3:50 PM
Workshop B – Panel 4

Exhibition Schedule
October 28 (Tue): 7:00 AM – 6:35 PM
October 29 (Wed): 7:00 AM – 6:35 PM
October 30 (Thu): 7:00 AM – 3:00 PM

Venue
DTM Exhibition Hall
GRAND BALLROOM ⑥, San Francisco Airport Marriott Waterfront, Burlingame, CA, USA

For more details, please visit the official 25th Diabetes Technology Meeting website:
https://www.afassanoco.com/ada/dtm.html

People may think of glucose monitoring as simple as this: "Diabetes is a disease of blood sugar. This is why people with diabetes use glucometer."
However, it's not that simple. Blood sugar measurement has diverse objectives, including diagnosing diabetes, dosing self-injection of insulin, avoiding hypoglycemia due to excessive drug efficacy, and behavior change.
You must choose the appropriate blood sugar measurement method for your purpose.

There are two types of self-blood glucose measurement methods: SMBG (Self-Monitoring of Blood Glucose), which is widely used, and CGM (Continuous Glucose Monitoring), which has become popular in recent years.
These two blood glucose measurement methods are designed mainly for patients who self-inject insulin and other injectable drugs.
Until now, there has been no simple and daily method for measuring blood glucose at home other than these two methods.

Some drugs, such as insulin, are very potent and can cause dangerous hypoglycemia if the dosage is incorrect.
Therefore, for example, those who use insulin must measure their blood glucose accurately before self-injection at home and carefully determine the dose.
After injection, if there are signs of hypoglycemia, it is necessary to measure blood glucose immediately. If necessary, you need to take some sugar to avoid hypoglycemia.
However, both methods have an issue with invasiveness. In addition, they cost a lot. CGM costs at least $60 and needs to be replaced every two weeks, which is also a significant economic burden. SMBG requires frequent measurements, so the total cost becomes significant when accumulated.
Unfortunately, SMBG and CGM are not suitable for everyone due to invasiveness and cost.